Skip to main content

Table 3 Topic raised according to type of sarcoma

From: Use of a simple form to facilitate communication on long-term consequences of treatment in sarcoma survivors

TopicDiagnosisN (%)Crude OR (95% CI)P-valueAdjusted ORa (95% CI)P-value
PainSTS27/106 (26)1.0 (ref) 1.0 (ref) 
BS19/54 (35)1.6 (0.8–3.2)0.201.5 (0.7–3.3)0.36
FatigueSTS32/106 (30)1.0 1.0 
BS31/54 (57)3.1 (1.6–6.2)0.0013.1 (1.4–6.7)0.004
Bowel/urinationSTS5/106 (5)1.0 1.0 
BS2/54 (4)0.8 (0.1–4.1)0.770.6 (.01–4.1)0.59
SexualSTS9/106 (8)1.0 1.0 
BS11/54 (20)2.8 (1.1–7.1)0.042.6 (0.8–7.7)0.10
MobilitySTS20/106 (19)1.0 1.0 
BS16/54 (30)1.8 (0.8–3.9)0.111.9 (0.8–4.5) 
PsychologicalSTS8/106 (8)1.0 1.0 
BS11/54 (20)3.1 (1.2–8.3)0.022.9 (0.9–8.5)0.05
OtherSTS14/106 (13)1.0 1.0 
BS9/54 (17)1.3 (0.5–3.3)0.561.4 (0.5–4.1)0.50
PeerSTS3/106 (3)1.0 1.0 
BS7/54 (13)5.1 (1.3–21)0.0210 (2.0–54)0.005
No topicSTS16/106 (15)1.0 1.0 
BS4/54 (7)0.4 (0.1–1.4)0.170.5 (0.1–1.8)0.27
  1. N are presented as number of patients that raised the topic within the diagnosis group with % in the brackets
  2. Italic values indicate significance of P-value (P < 0.05)
  3. STS soft-tissue sarcoma, BS bone sarcoma, OR odds ratio, CI confidence interval, ref reference
  4. aAdjusted for age and gender